-
A Breakthrough in Endometrial Cancer: New Chemotherapy-Free Treatment Shows Promise
A Shift in Cancer Care A landmark global Phase 3 clinical trial, led by a physician at Mount Sinai Medical Center, has unveiled encouraging results for patients with dMMR (mismatch repair deficient) endometrial cancer. The study demonstrates that a chemotherapy-free treatment regimen can significantly improve outcomes, marking a potential turning point in how this gynecological…
-
A New Hope in Cancer Treatment: FDA Grants Fast Track Designation to Faeth Therapeutics
NASDAQ: $FTH Advancing Targeted Cancer Therapy There is promising news in the landscape of oncology as Faeth Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to their investigational therapy, Piktor, when used in combination with paclitaxel. What is the Piktor and Paclitaxel Combination? This clinical development program…